Home > Research > Publications & Outputs > Possible mechanisms and biomarkers of resistanc...

Electronic data

  • N_O_D_21_00593_R1

    Rights statement: This is a pre-copy-editing, author-produced PDF of an article accepted for publication in Neuro-Oncology following peer review. The definitive publisher-authenticated version Rafael Roesler, Caroline Brunetto de Farias, André T Brunetto, Lauro Gregianin, Mariane Jaeger, Carolina Nör, Amanda Thomaz, Possible mechanisms and biomarkers of resistance to vismodegib in SHH medulloblastoma, Neuro-Oncology, 2022 24: 1210-1211, is available online at https://doi.org/10.1093/neuonc/noac061

    Accepted author manuscript, 1.27 MB, PDF document

    Embargo ends: 11/05/23

    Available under license: CC BY-NC: Creative Commons Attribution-NonCommercial 4.0 International License

Links

Text available via DOI:

View graph of relations

Possible mechanisms and biomarkers of resistance to vismodegib in SHH medulloblastoma

Research output: Contribution to Journal/MagazineJournal articlepeer-review

Published
  • Rafael Roesler
  • Caroline Brunetto de Farias
  • André T Brunetto
  • Lauro Gregianin
  • Mariane Jaeger
  • Carolina Nör
  • Amanda Thomaz
Close
<mark>Journal publication date</mark>31/07/2022
<mark>Journal</mark>Neuro-Oncology
Issue number7
Volume24
Number of pages2
Pages (from-to) 1210–1211
Publication StatusPublished
Early online date11/05/22
<mark>Original language</mark>English

Bibliographic note

This is a pre-copy-editing, author-produced PDF of an article accepted for publication in Neuro-Oncology following peer review. The definitive publisher-authenticated version Rafael Roesler, Caroline Brunetto de Farias, André T Brunetto, Lauro Gregianin, Mariane Jaeger, Carolina Nör, Amanda Thomaz, Possible mechanisms and biomarkers of resistance to vismodegib in SHH medulloblastoma, Neuro-Oncology, 2022 24: 1210-1211, is available online at https://doi.org/10.1093/neuonc/noac061